Phase 2 Randomized, Open-Label Study of Gs-5885 Administered Concomitantly With Gs-9451, Tegobuvir and Ribavirin...... Grant uri icon

Overview

total award amount

  • 23736.18

direct costs

  • 18988.94

sponsor award id

  • GS-US-248-0120

Background

Time

date/time interval

  • June 20, 2011 - June 20, 2014

Identity

PeopleSoft Contract Number

  • 00081951

local award id

  • 00081951